M&T Bank
LGND icon

M&T Bank’s Ligand Pharmaceuticals LGND Stock Holding History

M&T Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Buy
2,503
+1,289
+106% +$304K ﹤0.01% 1006
2026
Q1 		$242K Buy
+1,214
New +$240K ﹤0.01% 1472
2022
Q2 		– Sell
-5,647
Closed -$397K – 1675
2022
Q1 		$397K Sell
5,647
-10
-0.2% -$726 ﹤0.01% 1086
2021
Q4 		$545K Buy
5,657
+925
+20% +$85.5K ﹤0.01% 981
2021
Q3 		$412K Buy
4,732
+324
+7% +$25.1K ﹤0.01% 1094
2021
Q2 		$361K Buy
4,408
+1,587
+56% +$132K ﹤0.01% 1179
2021
Q1 		$268K Sell
2,821
-4,096
-59% -$387K ﹤0.01% 1284
2020
Q4 		$429K Hold
6,917
– – ﹤0.01% 1138
2020
Q3 		$411K Buy
6,917
+725
+12% +$49.5K ﹤0.01% 1078
2020
Q2 		$433K Sell
6,192
-63
-1% -$3.99K ﹤0.01% 1003
2020
Q1 		$284K Buy
+6,255
New +$355K ﹤0.01% 1154
2018
Q4 		– Sell
-1,597
Closed -$274K – 1504
2018
Q3 		$274K Sell
1,597
-420
-21% -$63.3K ﹤0.01% 1274
2018
Q2 		$261K Sell
2,017
-529
-21% -$59K ﹤0.01% 1294
2018
Q1 		$262K Sell
2,546
-575
-18% -$56.9K ﹤0.01% 1295
2017
Q4 		$267K Buy
3,121
+582
+23% +$50.4K ﹤0.01% 1293
2017
Q3 		$216K Buy
+2,539
New +$201K ﹤0.01% 1381

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M&T Bank's LGND Position: Q2 2026 in Review

M&T Bank increased its Ligand Pharmaceuticals (LGND) stake by 106% in Q2 2026, buying an estimated $304K and bringing the position to 2,503 shares worth $791K. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

M&T Bank first reported a position in LGND in Q3 2017 and has held it in 16 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • M&T Bank held 2,503 shares of Ligand Pharmaceuticals worth $791K as of Q2 2026.
  • M&T Bank bought 1,289 Ligand Pharmaceuticals shares in Q2 2026, an estimated $304K.
  • Ligand Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1006 holding.
  • M&T Bank first reported a position in Ligand Pharmaceuticals in Q3 2017 and has held it in 16 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.